4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-017738
Chief Scientific Officer sold 3,000 shares at an average $67.68 ($203,032)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2019-03-05 | Option exercise | +428 | $31.64 | $13,542 | 26,939 | D |
| Biller Scott Chief Scientific Officer | 2019-03-05 | Option exercise | +2,572 | $39.76 | $102,263 | 29,511 | D |
| Biller Scott Chief Scientific Officer | 2019-03-05 | Sale | −200 | $66.45 | $13,290 | 29,311 | D |
| Biller Scott Chief Scientific Officer | 2019-03-05 | Sale | −2,600 | $67.73 | $176,098 | 26,711 | D |
| Biller Scott Chief Scientific Officer | 2019-03-05 | Sale | −200 | $68.22 | $13,644 | 26,511 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2019-03-05 | Option exercise · Stock option (right to buy) | −428 | 11,354 | D | ||
| Biller Scott Chief Scientific Officer | 2019-03-05 | Option exercise · Stock option (right to buy) | −2,572 | 42,648 | D | ||
| Open-market sales · 3,000 sh · avg $67.68 · $203,032 | |||||||
Loading xslF345X03/doc4.xml…